Still A Long Way To Go Until Everyone Is Safe From COVID – and Vaccine Numbers Don’t Tell The Whole Story 17/12/2021 Riccardo Lampariello As more vaccine supplies finally become available to the world’s low-and middle-income countries (LMICs), the latent challenges that should have been addressed long before have emerged. Those include vaccine hesitancy and the ability of weak health systems to mount mass vaccination campaigns amidst other pressing health needs. Global policymakers need to shift their attention from […] Continue reading -> Some 78% of Africans Ready to Get COVID-19 Jab – But Only 7% Have Managed, Says New Survey 16/12/2021 Raisa Santos An overwhelming majority of people in Africa – 78% of people surveyed across 19 countries in the African Union – are willing to get vaccinated, according to new research from the Partnership for Evidence-Based Response to COVID-19 (PERC). PERC – a public-private partnership consisting of organizations and institutions such as the African Union, Africa Centres […] Continue reading -> African Medicines Agency Has Key Role as Continent Pushes Local Vaccine Production 07/12/2021 Kerry Cullinan The newly constituted African Medicines Agency (AMA) will be key in assisting the African Union (AU) to achieve its aim of producing 60% of vaccines on its own soil by 2040. This emerged at a two-day meeting of the Partnership for Africa Vaccine Manufacturing (PAVM) hosted by Rwanda this week. The PAVM was set up […] Continue reading -> Africa is Making Progress on Vaccine Development – But Big Pharma Warns That Process is Costly and Slow 06/12/2021 Kerry Cullinan The African Union has made steady progress to manufacture vaccines on the continent, but this is a complicated, expensive endeavour that required long-term commitment, Big Pharma companies warned. Welcoming delegates to the Partnership for African Vaccine Manufacturing (PAVM) reportback six months after it was set up, Rwandan President Paul Kagame said building pharmaceutical manufacturing […] Continue reading -> Europe Cannot ‘Treaty’ its Way Out of the Pandemic 30/11/2021 Unni Karunakara A special session of the World Health Assembly is under way this week with just one item under consideration – Pandemic Treaty. Will a pandemic treaty be able to help address deficiencies in global solidarity, and improve access to essential lifesaving medicines, vaccines, and tools? The short answer is no. Not without the political will […] Continue reading -> Milestone Moment for Pandemic Treaty in Geneva – US and Other Treaty Skeptics Swinging Behind Call to Negotiate a New Convention 26/11/2021 Elaine Ruth Fletcher As pandemic treaty negotiations kick off again at the World Health Organization (WHO) in Geneva this week, countries face a stark choice. Will they decide to move ahead on a new system that vests an independent entity with greater powers to monitor their own national alert and responses – in the name of faster pandemic […] Continue reading -> ‘Omicron’: New COVID-19 Variant With Multiple Concerning Mutations Identified in Southern Africa – USA & Europe Respond With Flurry of Travel Restrictions 25/11/2021 Kerry Cullinan CAPE TOWN – A new COVID-19 variant with a “very unusual constellation of mutations” – currently referred to as B.1.1.529 – has been identified in southern Africa, South Africa’s Health Ministry announced on Thursday. On Friday, WHO dubbed the variant “Omicron”, adding it to its list of variants of concern – even as the European […] Continue reading -> Russia Says Sputnik COVID-19 Vaccine Shows Better Efficacy Than mRNA Vaccines 24/11/2021 Raisa Santos Russia’s Sputnik V COVID-19 vaccine demonstrates an 80% efficacy six to eight months after the second dose – a higher efficacy than officially published mRNA vaccines, announced the Russian Direct Investment Fund (RDIF) in a press briefing on Wednesday. The efficacy data is based on “real-world data from the Ministry of Health of the Republic […] Continue reading -> C-TAP and Medicines Patent Pool Announce Global License for Spanish COVID-19 Test 23/11/2021 Raisa Santos The first non-exclusive license for a COVID-19 health tool – a serological antibody test that checks for the presence of anti-SARS-CoV-2 antibodies – has been finalised by the World Health Organization’s (WHO) COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP). The license, announced on Tuesday in partnership with the Spanish National Research […] Continue reading -> United States FDA Clears COVID Vaccine Boosters for All Adults Over 18 – Pfizer & Moderna 6 Months After Second Jab 19/11/2021 Elaine Ruth Fletcher The United States Food and Drug Administration (US FDA) on Friday gave its greenlight to the mass rollout of both Pfizer and Moderna COVID booster shots to all adults over the age of 18, from six months after a person’s second vaccine dose. J&J vaccine boosters would be authorized after just two months of the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Some 78% of Africans Ready to Get COVID-19 Jab – But Only 7% Have Managed, Says New Survey 16/12/2021 Raisa Santos An overwhelming majority of people in Africa – 78% of people surveyed across 19 countries in the African Union – are willing to get vaccinated, according to new research from the Partnership for Evidence-Based Response to COVID-19 (PERC). PERC – a public-private partnership consisting of organizations and institutions such as the African Union, Africa Centres […] Continue reading -> African Medicines Agency Has Key Role as Continent Pushes Local Vaccine Production 07/12/2021 Kerry Cullinan The newly constituted African Medicines Agency (AMA) will be key in assisting the African Union (AU) to achieve its aim of producing 60% of vaccines on its own soil by 2040. This emerged at a two-day meeting of the Partnership for Africa Vaccine Manufacturing (PAVM) hosted by Rwanda this week. The PAVM was set up […] Continue reading -> Africa is Making Progress on Vaccine Development – But Big Pharma Warns That Process is Costly and Slow 06/12/2021 Kerry Cullinan The African Union has made steady progress to manufacture vaccines on the continent, but this is a complicated, expensive endeavour that required long-term commitment, Big Pharma companies warned. Welcoming delegates to the Partnership for African Vaccine Manufacturing (PAVM) reportback six months after it was set up, Rwandan President Paul Kagame said building pharmaceutical manufacturing […] Continue reading -> Europe Cannot ‘Treaty’ its Way Out of the Pandemic 30/11/2021 Unni Karunakara A special session of the World Health Assembly is under way this week with just one item under consideration – Pandemic Treaty. Will a pandemic treaty be able to help address deficiencies in global solidarity, and improve access to essential lifesaving medicines, vaccines, and tools? The short answer is no. Not without the political will […] Continue reading -> Milestone Moment for Pandemic Treaty in Geneva – US and Other Treaty Skeptics Swinging Behind Call to Negotiate a New Convention 26/11/2021 Elaine Ruth Fletcher As pandemic treaty negotiations kick off again at the World Health Organization (WHO) in Geneva this week, countries face a stark choice. Will they decide to move ahead on a new system that vests an independent entity with greater powers to monitor their own national alert and responses – in the name of faster pandemic […] Continue reading -> ‘Omicron’: New COVID-19 Variant With Multiple Concerning Mutations Identified in Southern Africa – USA & Europe Respond With Flurry of Travel Restrictions 25/11/2021 Kerry Cullinan CAPE TOWN – A new COVID-19 variant with a “very unusual constellation of mutations” – currently referred to as B.1.1.529 – has been identified in southern Africa, South Africa’s Health Ministry announced on Thursday. On Friday, WHO dubbed the variant “Omicron”, adding it to its list of variants of concern – even as the European […] Continue reading -> Russia Says Sputnik COVID-19 Vaccine Shows Better Efficacy Than mRNA Vaccines 24/11/2021 Raisa Santos Russia’s Sputnik V COVID-19 vaccine demonstrates an 80% efficacy six to eight months after the second dose – a higher efficacy than officially published mRNA vaccines, announced the Russian Direct Investment Fund (RDIF) in a press briefing on Wednesday. The efficacy data is based on “real-world data from the Ministry of Health of the Republic […] Continue reading -> C-TAP and Medicines Patent Pool Announce Global License for Spanish COVID-19 Test 23/11/2021 Raisa Santos The first non-exclusive license for a COVID-19 health tool – a serological antibody test that checks for the presence of anti-SARS-CoV-2 antibodies – has been finalised by the World Health Organization’s (WHO) COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP). The license, announced on Tuesday in partnership with the Spanish National Research […] Continue reading -> United States FDA Clears COVID Vaccine Boosters for All Adults Over 18 – Pfizer & Moderna 6 Months After Second Jab 19/11/2021 Elaine Ruth Fletcher The United States Food and Drug Administration (US FDA) on Friday gave its greenlight to the mass rollout of both Pfizer and Moderna COVID booster shots to all adults over the age of 18, from six months after a person’s second vaccine dose. J&J vaccine boosters would be authorized after just two months of the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
African Medicines Agency Has Key Role as Continent Pushes Local Vaccine Production 07/12/2021 Kerry Cullinan The newly constituted African Medicines Agency (AMA) will be key in assisting the African Union (AU) to achieve its aim of producing 60% of vaccines on its own soil by 2040. This emerged at a two-day meeting of the Partnership for Africa Vaccine Manufacturing (PAVM) hosted by Rwanda this week. The PAVM was set up […] Continue reading -> Africa is Making Progress on Vaccine Development – But Big Pharma Warns That Process is Costly and Slow 06/12/2021 Kerry Cullinan The African Union has made steady progress to manufacture vaccines on the continent, but this is a complicated, expensive endeavour that required long-term commitment, Big Pharma companies warned. Welcoming delegates to the Partnership for African Vaccine Manufacturing (PAVM) reportback six months after it was set up, Rwandan President Paul Kagame said building pharmaceutical manufacturing […] Continue reading -> Europe Cannot ‘Treaty’ its Way Out of the Pandemic 30/11/2021 Unni Karunakara A special session of the World Health Assembly is under way this week with just one item under consideration – Pandemic Treaty. Will a pandemic treaty be able to help address deficiencies in global solidarity, and improve access to essential lifesaving medicines, vaccines, and tools? The short answer is no. Not without the political will […] Continue reading -> Milestone Moment for Pandemic Treaty in Geneva – US and Other Treaty Skeptics Swinging Behind Call to Negotiate a New Convention 26/11/2021 Elaine Ruth Fletcher As pandemic treaty negotiations kick off again at the World Health Organization (WHO) in Geneva this week, countries face a stark choice. Will they decide to move ahead on a new system that vests an independent entity with greater powers to monitor their own national alert and responses – in the name of faster pandemic […] Continue reading -> ‘Omicron’: New COVID-19 Variant With Multiple Concerning Mutations Identified in Southern Africa – USA & Europe Respond With Flurry of Travel Restrictions 25/11/2021 Kerry Cullinan CAPE TOWN – A new COVID-19 variant with a “very unusual constellation of mutations” – currently referred to as B.1.1.529 – has been identified in southern Africa, South Africa’s Health Ministry announced on Thursday. On Friday, WHO dubbed the variant “Omicron”, adding it to its list of variants of concern – even as the European […] Continue reading -> Russia Says Sputnik COVID-19 Vaccine Shows Better Efficacy Than mRNA Vaccines 24/11/2021 Raisa Santos Russia’s Sputnik V COVID-19 vaccine demonstrates an 80% efficacy six to eight months after the second dose – a higher efficacy than officially published mRNA vaccines, announced the Russian Direct Investment Fund (RDIF) in a press briefing on Wednesday. The efficacy data is based on “real-world data from the Ministry of Health of the Republic […] Continue reading -> C-TAP and Medicines Patent Pool Announce Global License for Spanish COVID-19 Test 23/11/2021 Raisa Santos The first non-exclusive license for a COVID-19 health tool – a serological antibody test that checks for the presence of anti-SARS-CoV-2 antibodies – has been finalised by the World Health Organization’s (WHO) COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP). The license, announced on Tuesday in partnership with the Spanish National Research […] Continue reading -> United States FDA Clears COVID Vaccine Boosters for All Adults Over 18 – Pfizer & Moderna 6 Months After Second Jab 19/11/2021 Elaine Ruth Fletcher The United States Food and Drug Administration (US FDA) on Friday gave its greenlight to the mass rollout of both Pfizer and Moderna COVID booster shots to all adults over the age of 18, from six months after a person’s second vaccine dose. J&J vaccine boosters would be authorized after just two months of the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Africa is Making Progress on Vaccine Development – But Big Pharma Warns That Process is Costly and Slow 06/12/2021 Kerry Cullinan The African Union has made steady progress to manufacture vaccines on the continent, but this is a complicated, expensive endeavour that required long-term commitment, Big Pharma companies warned. Welcoming delegates to the Partnership for African Vaccine Manufacturing (PAVM) reportback six months after it was set up, Rwandan President Paul Kagame said building pharmaceutical manufacturing […] Continue reading -> Europe Cannot ‘Treaty’ its Way Out of the Pandemic 30/11/2021 Unni Karunakara A special session of the World Health Assembly is under way this week with just one item under consideration – Pandemic Treaty. Will a pandemic treaty be able to help address deficiencies in global solidarity, and improve access to essential lifesaving medicines, vaccines, and tools? The short answer is no. Not without the political will […] Continue reading -> Milestone Moment for Pandemic Treaty in Geneva – US and Other Treaty Skeptics Swinging Behind Call to Negotiate a New Convention 26/11/2021 Elaine Ruth Fletcher As pandemic treaty negotiations kick off again at the World Health Organization (WHO) in Geneva this week, countries face a stark choice. Will they decide to move ahead on a new system that vests an independent entity with greater powers to monitor their own national alert and responses – in the name of faster pandemic […] Continue reading -> ‘Omicron’: New COVID-19 Variant With Multiple Concerning Mutations Identified in Southern Africa – USA & Europe Respond With Flurry of Travel Restrictions 25/11/2021 Kerry Cullinan CAPE TOWN – A new COVID-19 variant with a “very unusual constellation of mutations” – currently referred to as B.1.1.529 – has been identified in southern Africa, South Africa’s Health Ministry announced on Thursday. On Friday, WHO dubbed the variant “Omicron”, adding it to its list of variants of concern – even as the European […] Continue reading -> Russia Says Sputnik COVID-19 Vaccine Shows Better Efficacy Than mRNA Vaccines 24/11/2021 Raisa Santos Russia’s Sputnik V COVID-19 vaccine demonstrates an 80% efficacy six to eight months after the second dose – a higher efficacy than officially published mRNA vaccines, announced the Russian Direct Investment Fund (RDIF) in a press briefing on Wednesday. The efficacy data is based on “real-world data from the Ministry of Health of the Republic […] Continue reading -> C-TAP and Medicines Patent Pool Announce Global License for Spanish COVID-19 Test 23/11/2021 Raisa Santos The first non-exclusive license for a COVID-19 health tool – a serological antibody test that checks for the presence of anti-SARS-CoV-2 antibodies – has been finalised by the World Health Organization’s (WHO) COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP). The license, announced on Tuesday in partnership with the Spanish National Research […] Continue reading -> United States FDA Clears COVID Vaccine Boosters for All Adults Over 18 – Pfizer & Moderna 6 Months After Second Jab 19/11/2021 Elaine Ruth Fletcher The United States Food and Drug Administration (US FDA) on Friday gave its greenlight to the mass rollout of both Pfizer and Moderna COVID booster shots to all adults over the age of 18, from six months after a person’s second vaccine dose. J&J vaccine boosters would be authorized after just two months of the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Europe Cannot ‘Treaty’ its Way Out of the Pandemic 30/11/2021 Unni Karunakara A special session of the World Health Assembly is under way this week with just one item under consideration – Pandemic Treaty. Will a pandemic treaty be able to help address deficiencies in global solidarity, and improve access to essential lifesaving medicines, vaccines, and tools? The short answer is no. Not without the political will […] Continue reading -> Milestone Moment for Pandemic Treaty in Geneva – US and Other Treaty Skeptics Swinging Behind Call to Negotiate a New Convention 26/11/2021 Elaine Ruth Fletcher As pandemic treaty negotiations kick off again at the World Health Organization (WHO) in Geneva this week, countries face a stark choice. Will they decide to move ahead on a new system that vests an independent entity with greater powers to monitor their own national alert and responses – in the name of faster pandemic […] Continue reading -> ‘Omicron’: New COVID-19 Variant With Multiple Concerning Mutations Identified in Southern Africa – USA & Europe Respond With Flurry of Travel Restrictions 25/11/2021 Kerry Cullinan CAPE TOWN – A new COVID-19 variant with a “very unusual constellation of mutations” – currently referred to as B.1.1.529 – has been identified in southern Africa, South Africa’s Health Ministry announced on Thursday. On Friday, WHO dubbed the variant “Omicron”, adding it to its list of variants of concern – even as the European […] Continue reading -> Russia Says Sputnik COVID-19 Vaccine Shows Better Efficacy Than mRNA Vaccines 24/11/2021 Raisa Santos Russia’s Sputnik V COVID-19 vaccine demonstrates an 80% efficacy six to eight months after the second dose – a higher efficacy than officially published mRNA vaccines, announced the Russian Direct Investment Fund (RDIF) in a press briefing on Wednesday. The efficacy data is based on “real-world data from the Ministry of Health of the Republic […] Continue reading -> C-TAP and Medicines Patent Pool Announce Global License for Spanish COVID-19 Test 23/11/2021 Raisa Santos The first non-exclusive license for a COVID-19 health tool – a serological antibody test that checks for the presence of anti-SARS-CoV-2 antibodies – has been finalised by the World Health Organization’s (WHO) COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP). The license, announced on Tuesday in partnership with the Spanish National Research […] Continue reading -> United States FDA Clears COVID Vaccine Boosters for All Adults Over 18 – Pfizer & Moderna 6 Months After Second Jab 19/11/2021 Elaine Ruth Fletcher The United States Food and Drug Administration (US FDA) on Friday gave its greenlight to the mass rollout of both Pfizer and Moderna COVID booster shots to all adults over the age of 18, from six months after a person’s second vaccine dose. J&J vaccine boosters would be authorized after just two months of the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Milestone Moment for Pandemic Treaty in Geneva – US and Other Treaty Skeptics Swinging Behind Call to Negotiate a New Convention 26/11/2021 Elaine Ruth Fletcher As pandemic treaty negotiations kick off again at the World Health Organization (WHO) in Geneva this week, countries face a stark choice. Will they decide to move ahead on a new system that vests an independent entity with greater powers to monitor their own national alert and responses – in the name of faster pandemic […] Continue reading -> ‘Omicron’: New COVID-19 Variant With Multiple Concerning Mutations Identified in Southern Africa – USA & Europe Respond With Flurry of Travel Restrictions 25/11/2021 Kerry Cullinan CAPE TOWN – A new COVID-19 variant with a “very unusual constellation of mutations” – currently referred to as B.1.1.529 – has been identified in southern Africa, South Africa’s Health Ministry announced on Thursday. On Friday, WHO dubbed the variant “Omicron”, adding it to its list of variants of concern – even as the European […] Continue reading -> Russia Says Sputnik COVID-19 Vaccine Shows Better Efficacy Than mRNA Vaccines 24/11/2021 Raisa Santos Russia’s Sputnik V COVID-19 vaccine demonstrates an 80% efficacy six to eight months after the second dose – a higher efficacy than officially published mRNA vaccines, announced the Russian Direct Investment Fund (RDIF) in a press briefing on Wednesday. The efficacy data is based on “real-world data from the Ministry of Health of the Republic […] Continue reading -> C-TAP and Medicines Patent Pool Announce Global License for Spanish COVID-19 Test 23/11/2021 Raisa Santos The first non-exclusive license for a COVID-19 health tool – a serological antibody test that checks for the presence of anti-SARS-CoV-2 antibodies – has been finalised by the World Health Organization’s (WHO) COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP). The license, announced on Tuesday in partnership with the Spanish National Research […] Continue reading -> United States FDA Clears COVID Vaccine Boosters for All Adults Over 18 – Pfizer & Moderna 6 Months After Second Jab 19/11/2021 Elaine Ruth Fletcher The United States Food and Drug Administration (US FDA) on Friday gave its greenlight to the mass rollout of both Pfizer and Moderna COVID booster shots to all adults over the age of 18, from six months after a person’s second vaccine dose. J&J vaccine boosters would be authorized after just two months of the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
‘Omicron’: New COVID-19 Variant With Multiple Concerning Mutations Identified in Southern Africa – USA & Europe Respond With Flurry of Travel Restrictions 25/11/2021 Kerry Cullinan CAPE TOWN – A new COVID-19 variant with a “very unusual constellation of mutations” – currently referred to as B.1.1.529 – has been identified in southern Africa, South Africa’s Health Ministry announced on Thursday. On Friday, WHO dubbed the variant “Omicron”, adding it to its list of variants of concern – even as the European […] Continue reading -> Russia Says Sputnik COVID-19 Vaccine Shows Better Efficacy Than mRNA Vaccines 24/11/2021 Raisa Santos Russia’s Sputnik V COVID-19 vaccine demonstrates an 80% efficacy six to eight months after the second dose – a higher efficacy than officially published mRNA vaccines, announced the Russian Direct Investment Fund (RDIF) in a press briefing on Wednesday. The efficacy data is based on “real-world data from the Ministry of Health of the Republic […] Continue reading -> C-TAP and Medicines Patent Pool Announce Global License for Spanish COVID-19 Test 23/11/2021 Raisa Santos The first non-exclusive license for a COVID-19 health tool – a serological antibody test that checks for the presence of anti-SARS-CoV-2 antibodies – has been finalised by the World Health Organization’s (WHO) COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP). The license, announced on Tuesday in partnership with the Spanish National Research […] Continue reading -> United States FDA Clears COVID Vaccine Boosters for All Adults Over 18 – Pfizer & Moderna 6 Months After Second Jab 19/11/2021 Elaine Ruth Fletcher The United States Food and Drug Administration (US FDA) on Friday gave its greenlight to the mass rollout of both Pfizer and Moderna COVID booster shots to all adults over the age of 18, from six months after a person’s second vaccine dose. J&J vaccine boosters would be authorized after just two months of the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Russia Says Sputnik COVID-19 Vaccine Shows Better Efficacy Than mRNA Vaccines 24/11/2021 Raisa Santos Russia’s Sputnik V COVID-19 vaccine demonstrates an 80% efficacy six to eight months after the second dose – a higher efficacy than officially published mRNA vaccines, announced the Russian Direct Investment Fund (RDIF) in a press briefing on Wednesday. The efficacy data is based on “real-world data from the Ministry of Health of the Republic […] Continue reading -> C-TAP and Medicines Patent Pool Announce Global License for Spanish COVID-19 Test 23/11/2021 Raisa Santos The first non-exclusive license for a COVID-19 health tool – a serological antibody test that checks for the presence of anti-SARS-CoV-2 antibodies – has been finalised by the World Health Organization’s (WHO) COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP). The license, announced on Tuesday in partnership with the Spanish National Research […] Continue reading -> United States FDA Clears COVID Vaccine Boosters for All Adults Over 18 – Pfizer & Moderna 6 Months After Second Jab 19/11/2021 Elaine Ruth Fletcher The United States Food and Drug Administration (US FDA) on Friday gave its greenlight to the mass rollout of both Pfizer and Moderna COVID booster shots to all adults over the age of 18, from six months after a person’s second vaccine dose. J&J vaccine boosters would be authorized after just two months of the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
C-TAP and Medicines Patent Pool Announce Global License for Spanish COVID-19 Test 23/11/2021 Raisa Santos The first non-exclusive license for a COVID-19 health tool – a serological antibody test that checks for the presence of anti-SARS-CoV-2 antibodies – has been finalised by the World Health Organization’s (WHO) COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP). The license, announced on Tuesday in partnership with the Spanish National Research […] Continue reading -> United States FDA Clears COVID Vaccine Boosters for All Adults Over 18 – Pfizer & Moderna 6 Months After Second Jab 19/11/2021 Elaine Ruth Fletcher The United States Food and Drug Administration (US FDA) on Friday gave its greenlight to the mass rollout of both Pfizer and Moderna COVID booster shots to all adults over the age of 18, from six months after a person’s second vaccine dose. J&J vaccine boosters would be authorized after just two months of the […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
United States FDA Clears COVID Vaccine Boosters for All Adults Over 18 – Pfizer & Moderna 6 Months After Second Jab 19/11/2021 Elaine Ruth Fletcher The United States Food and Drug Administration (US FDA) on Friday gave its greenlight to the mass rollout of both Pfizer and Moderna COVID booster shots to all adults over the age of 18, from six months after a person’s second vaccine dose. J&J vaccine boosters would be authorized after just two months of the […] Continue reading -> Posts navigation Older postsNewer posts